Dermatologic Malignancies | Norton Healthcare

Indication: Dermatologic Malignancies

Phase 2 Study of INCMGA00012 in Patients with Metastatic Merkel Cell Carcinoma (POD1UM-201)

Sub-indication: Dermatologic Malignancies

Drug Study

Principal Investigator: Jaspreet Grewal, M.D.
Norton Cancer Institute

Sponsor: Incyte Corporation

Learn more at ClinicalTrials.gov

Email for more information: Derm-NCIResearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.